This experimental approach in budding yeast provides the first evidence that H3K36-mutant tumors may be candidates for TIP60 inhibition, but subsequent experimentation in H3K36-mutant human cancer cell lines is required to test this hypothesis. Here, KAT5 is linked to cancer.